Sunday 18 October 2026
Export APMD’s income statement to Excel — free account
Apnimed, Inc.
APMD
Apnimed, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.5 million, up 380.1% from fiscal 2024. Insiders bought in the last twelve months.
17.76
0.49
−2.68%
Follow APMD
| Older periods | Jun '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+1 more TTM period Free account |
— | — | — | 0.00% | |
| — | — | — | 0.00% | ||
ROIC |
— | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
— | 0.00% | 0.00% | 64.01% | |
Average Days of Receivables |
— | 0.00 | 0.00 | 2.15 | |
Free Cash Flow per Share |
0.00 | — | 0.00 | (17.46) | |
Free Cash Flow |
— | — | — | (83.75) | |
| Other line items | |||||
Cash ROIC |
— | 0.00% | 0.00% | (109.87%) | |
Accounts Receivable Turnover |
— | — | — | 0.00 | |
Accounts Payable Turnover |
— | — | — | 0.00 | |
Inventory Turnover |
— | — | — | 0.00 | |
Average Days of Payables |
— | 0.00 | 0.00 | 375.65 | |
Days of Inventory on Hand |
— | — | — | 0.00 | |
Tax Rate |
— | — | — | 0.00 | |
Research and Development Expense of Revenue |
— | — | — | 49.03% | |
Selling, General and Administrative Expense of Revenue |
— | — | — | 25.61% | |
Share Based Compensation of Revenue |
— | — | — | 3.23% | |
Operating CF/Net income |
— | — | — | (0.88) | |
Depreciation/Fixed assets |
— | 0.00 | 0.00 | 0.49 | |
Capex/Depreciation |
— | — | — | 0.00 | |
Revenue per Share |
0.00 | — | 0.00 | 24.42 | |
Operating CF per Share |
0.00 | — | 0.00 | (17.46) | |
Capex per Share |
0.00 | — | 0.00 | 0.00 | |
Capex to Sales |
— | — | — | 0.00 |
Columns are period end dates · fundamentals updated 7 Oct 2026